-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CeY6OpFYcpTlsHaxBRY2EJSDTuLNYFKbPb7rfy9YlVNNU6lcE8+mFR1WamKTALkC io8YbGMF4Q/SSKvdFuxxRw== 0001144204-07-022752.txt : 20070504 0001144204-07-022752.hdr.sgml : 20070504 20070504130230 ACCESSION NUMBER: 0001144204-07-022752 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070430 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant FILED AS OF DATE: 20070504 DATE AS OF CHANGE: 20070504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN MEDICAL ALERT CORP CENTRAL INDEX KEY: 0000700721 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] IRS NUMBER: 112571221 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08635 FILM NUMBER: 07819195 BUSINESS ADDRESS: STREET 1: 3265 LAWSON BLVD CITY: OCEANSIDE STATE: NY ZIP: 11572 BUSINESS PHONE: 5165365850 MAIL ADDRESS: STREET 1: 3265 LAWSON BLVD CITY: OCEANSIDE STATE: NY ZIP: 11572 8-K 1 v073773_8k.htm Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported): April 30, 2007



American Medical Alert Corp.
(Exact name of registrant as specified in its charter)


New York
333-54992
11-2571221
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)


3265 Lawson Boulevard, Oceanside, New York
11572
(Address of Principal Executive Offices)
(Zip Code)


Registrant's telephone number, including area code: (516) 536-5850


Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
□
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
□
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
□
Pre-commencement of communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)
 
□
Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))





 
 
 


Item 1.01 Entry into a Material Definitive Agreement.

On April 30, 2007, the Company entered into an amendment to its credit agreement with JPMorgan Chase Bank, as successor in the interest to the Bank of New York. Pursuant to the amendment, the Company’ revolving credit line was increased from $1,500,000 to $2,500,000 and extended until June 30, 2010. For a description of the material terms of the amendment, See Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, set forth below.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

On April 30, 2007, the Company entered into an amendment to its credit agreement, dated May 20, 2002, with JPMorgan Chase Bank, as successor in the interest to the Bank of New York (the "Bank"). Pursuant to the amendment, the Company’s revolving credit line was increased from $1,500,000 to $2,500,000 and extended until June 30, 2010. The revolving credit line is evidenced by a promissory note (the "Note"). The Note expires on June 30, 2010 bears interest at either (i) an annual rate of LIBOR + 1.75% or (ii) the prime rate or the federal funds effective rate plus 0.5%, whichever is greater, and is payable prior to its expiration. The Note may be accelerated upon the occurrence of an event of default (as defined in the credit agreement).


 
 
 

SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 3, 2007

     
 
AMERICAN MEDICAL ALERT CORP.
     
     
 
By:
/s/ Richard Rallo
   
Name: Richard Rallo
   
Title: Chief Financial Officer



-----END PRIVACY-ENHANCED MESSAGE-----